What Makes Dual Agonists Unique in Obesity Treatment Dual agonists represent the next evolution in hormonal therapies for obesity
Cardiovascular outcomes and mortality after initiation of canagliflozin: analyses from the EASEL Study
10.1210/jc.2019-00780 96 PanagiotopoulouO.SyngelakiA.GeorgiopoulosG.SimpsonJ.AkolekarR.ShehataH.et al (2020)
Blood clots can occur in veins (venous thromboembolism) or arteries (arterial thrombosis), each presenting with distinct symptom patterns
number and diameter of blood vessels, epithelization and collagen
GLP-1 signaling, the part both peptides share, works the brain and pancreas: it makes you feel full, slows the stomach down, releases insulin when glucose runs high, and drags blood sugar lower